Trump’s Fed Power Grab? 04/26/24
Podcast |
Squawk Pod
Publisher |
CNBC
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
Apr 26, 2024
Episode Duration |
00:30:13

Former President Donald Trump's political allies are crafting a plan to increase his advisors-are-considering-plans-to-dramatically-revamp-the-fed-wsj-report-says.html">influence over the Federal Reserve, potentially even making him an "acting" member of the central bank’s board, according to The Wall Street Journal. Nick Timiraos, the Journal's Chief Economics Correspondent, discusses the implications if Trump wins in November. Former FDA Commissioner Dr. Scott Gottlieb weighs in on Moderna's partnership with OpenAI, the AI drug revolution, his own AI venture, and updates on the bird flu presence in America’s pasteurized milk. Plus, CNBC's Steve Kovach breaks down set-to-report-first-quarter-results-after-market-close.html">Alphabet and msft-q3-earnings-2024.html">Microsoft earnings and explores the future of AI investment for the megacap tech companies.

 

Nick Timiraos - 10:08

Steve Kovach - 17:22

Dr. Scott Gottlieb - 22:12

.

In this episode:

Nick Timiraos, @NickTimiraos

Scott Gottlieb, @ScottGottliebMD

Joe Kernen, @JoeSquawk

Becky Quick, @BeckyQuick

Andrew Ross Sorkin, @andrewrsorkin

Zach Vallese, @zachvallese

Former President Donald Trump's political allies are crafting a plan to increase his influence over the Federal Reserve, potentially even making him an "acting" member of the central bank’s board, according to The Wall Street Journal. Nick Timiraos, the Journal's Chief Economics Correspondent, discusses the implications if Trump wins in November. Former FDA Commissioner Dr. Scott Gottlieb weighs in on Moderna's partnership with OpenAI, the AI drug revolution, his own AI venture, and updates on the bird flu presence in America’s pasteurized milk. Plus, CNBC's Steve Kovach breaks down Alphabet and Microsoft earnings and explores the future of AI investment for the megacap tech companies. Nick Timiraos - 10:08 Steve Kovach - 17:22 Dr. Scott Gottlieb - 22:12 . In this episode: Nick Timiraos, @NickTimiraos Scott Gottlieb, @ScottGottliebMD Joe Kernen, @JoeSquawk Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Zach Vallese, @zachvallese

Former President Donald Trump's political allies are crafting a plan to increase his advisors-are-considering-plans-to-dramatically-revamp-the-fed-wsj-report-says.html">influence over the Federal Reserve, potentially even making him an "acting" member of the central bank’s board, according to The Wall Street Journal. Nick Timiraos, the Journal's Chief Economics Correspondent, discusses the implications if Trump wins in November. Former FDA Commissioner Dr. Scott Gottlieb weighs in on Moderna's partnership with OpenAI, the AI drug revolution, his own AI venture, and updates on the bird flu presence in America’s pasteurized milk. Plus, CNBC's Steve Kovach breaks down set-to-report-first-quarter-results-after-market-close.html">Alphabet and msft-q3-earnings-2024.html">Microsoft earnings and explores the future of AI investment for the megacap tech companies.

 

Nick Timiraos - 10:08

Steve Kovach - 17:22

Dr. Scott Gottlieb - 22:12

.

In this episode:

Nick Timiraos, @NickTimiraos

Scott Gottlieb, @ScottGottliebMD

Joe Kernen, @JoeSquawk

Becky Quick, @BeckyQuick

Andrew Ross Sorkin, @andrewrsorkin

Zach Vallese, @zachvallese

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review